Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Clin Pharmacol Ther. 2019 Jul 26;106(3):525–543. doi: 10.1002/cpt.1537

Table 3:

Designating DMPK/PD applications using a tiered, fit-for-purpose approach

Characteristics DMPK/PD applications Optimum LC-MS approaches
Tier 1: Precise and accurate assays
• Absolute protein quantification
• The ability to measure repeatedly sets of analytes of interest within and across samples/experiments (A)
• These assays employ internal standards for each analyte, for confident detection and precise quantification (B).
• High level of validation required
• Protein complex stoichiometry (hetero-complexes)
• Systems biology and QSP modelling
• Cross-laboratory comparison
• Quantification and comparison of multiple proteins in different samples
• Assessment of isoform distribution and allelic variants
• Long-term use of historical protein abundance data in PBPK modeling
• Protein networks and alterations in disease
• MRM/PRM using PSAQ standards
• MRM using AQUA/QconCAT standards
       

Tier 2: Precise assays
• Characteristics A and B • Use in PBPK modeling and IVIVE
• Protein biomarker analysis
• Inter-experiment comparison
• Induction/suppression of abundance relative to control condition
• Inter-organism differences
• MRM/PRM using AQUA/QconCAT standards
• Global TPA
       

Tier 3: Semi-quantitative assays • High-throughput (shotgun proteomics)
• High coverage
• Method development
• Semi-quantitative analysis
• Regional and sub-cellular localization of proteins
• Biomarker discovery
• Discovery-scale DDA, DIA/SWATH